Day: May 2, 2024

First quarter cloud subscription revenue increased 24% year-over-year to $86.6 million MCLEAN, Va., May 02, 2024 (GLOBE NEWSWIRE) — Appian (Nasdaq: APPN) today announced financial results for the first quarter ended March 31, 2024. “Appian continues to push technological boundaries in our industry, from AI-backed services to process mining. Organizations globally are recognizing the power and simplicity of the Appian Platform,” said Matt Calkins, CEO & Founder. First Quarter 2024 Financial Highlights:Revenue: Cloud subscription revenue was $86.6 million, up 24% compared to the first quarter of 2023. Total subscriptions revenue, which includes sales of our cloud subscriptions, on-premises term license subscriptions, and maintenance and support, increased 19% year-over-year to $117.7 million. Professional services revenue...

KT-474/SAR444656 (IRAK4) Phase 2 clinical trials ongoing in HS and AD with data expected in the first half of 2025 KT-621 (STAT6) expected to start Phase 1 in the second half of 2024 and KT-294 (TYK2) expected to start Phase 1 in the first half of 2025, both with Phase 1 data in 2025 KT-253 (MDM2) and KT-333 (STAT3) Phase 1 dose escalation studies ongoing with clinical data updates at ASCO and EHA, respectively Well-capitalized with $745 million in cash as of March 31, 2024, and runway into the first half of 2027 Company to hold call and webcast today at 8:30 a.m. ET WATERTOWN, Mass., May 02, 2024 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein degradation (TPD), today reported financial results for the...

– Topline Data Readout from the Phase 3 ENERGIZE-T Study of Mitapivat in Adults with Transfusion-Dependent Alpha- or Beta-Thalassemia now expected in Q2 2024 – – Announced Positive Results from the Phase 3 ENERGIZE Study of Mitapivat in Adults with Non-Transfusion-Dependent Alpha- or Beta-Thalassemia in January – – Phase 3 Readouts from Mitapivat RISE UP Study in Sickle Cell Disease, ACTIVATE-KIDS and ACTIVATE KIDS-T in Pediatric PK Deficiency, All Expected by End of 2025 – – PYRUKYND® (Mitapivat) Net Revenue of $8.2 Million in Q1; Cash, Cash Equivalents and Marketable Securities of $714.3 Million as of March 31, 2024 – CAMBRIDGE, Mass., May 02, 2024 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today reported business highlights...

Maintaining previously issued fiscal full year 2024 outlook Fiscal Second Quarter 2024 HighlightsRevenue decreased 7% to $488 million Same-store sales decreased 5% for the quarter; average annual increase of 4% over last two years Gross profit margin of 24.6% GAAP net loss of $(5) million, or $(0.27) per diluted share and adjusted diluted earnings per share1 of $0.67 Adjusted EBITDA1 was $28 millionBUFORD, Ga., May 02, 2024 (GLOBE NEWSWIRE) — OneWater Marine Inc. (NASDAQ: ONEW) (“OneWater” or the “Company”) today announced results for its fiscal second quarter ended March 31, 2024. “Our second quarter results were largely in line with our expectations and historical seasonality as we continue to outperform the industry. Like the first quarter, the selling environment remains competitive and boat pricing continues to moderate....

LOUDON, Tenn., May 02, 2024 (GLOBE NEWSWIRE) — Malibu Boats, Inc. (Nasdaq: MBUU) today announced its financial results for the third quarter ended March 31, 2024. Third Quarter Fiscal 2024 Highlights Compared to Third Quarter Fiscal 2023:Net sales decreased 45.8% to $203.4 million Unit volume decreased 51.9% to 1,269 units Gross profit decreased 59.1% to $40.3 million GAAP net income decreased 226.8% to a net loss of $67.8 million, inclusive of goodwill and other intangible asset impairment charges of $88.4 million incurred for the Maverick Boat Group reporting unit GAAP net income available to Class A Common Stock per share (diluted) decreased 230.7% to a net loss of $3.28 per share Adjusted EBITDA decreased 69.2% to $24.4 million Adjusted fully distributed net income per share decreased 75.7% to $0.63 per share on a fully...

First Quarter 2024Worldwide revenue of $370.0 million, an increase of 23.0% from first quarter 2023  GAAP fully diluted net income per share of $1.87, compared to GAAP fully diluted net loss per share of $0.04 in first quarter 2023. Adjusted fully diluted net income per share of $1.69 compared to adjusted fully diluted net income per share of $1.47 in the first quarter 2023 The Company increases full year 2024 net revenue and earnings guidance and provides guidance for the second quarter 2024BEDFORD, Mass., May 02, 2024 (GLOBE NEWSWIRE) — Lantheus Holdings, Inc. (the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today reported financial results for its first quarter ended March 31, 2024. “Strong...

Harsco Rail Now Reported Within Continuing Operations As Sales Process is PausedFirst Quarter Revenues Totaled $600 Million, an Increase of 7 Percent Over the Prior-Year QuarterQ1 GAAP Operating Income of $26 MillionAdjusted EBITDA in Q1 Totaled $78 million, an Increase of 19 Percent Over the Prior-Year QuarterHarsco Environmental and Clean Earth Adjusted Earnings Growth (Year-on-Year) Exceeded Prior Guidance for the Quarter2024 Adjusted EBITDA Now Expected to be Within Range of $325 Million and $342 Million Including Harsco RailPHILADELPHIA, May 02, 2024 (GLOBE NEWSWIRE) — Enviri Corporation (NYSE: NVRI) today reported first quarter 2024 results. Revenues in the first quarter of 2024 totaled $600 million, an increase of 7 percent compared with the comparable quarter in 2023. GAAP operating income from continuing...

Adjusted EBITDA(1) growth of 5% YOYDigital-only subscription revenue increased 48%(2) with subscriptions up 25%Total Digital Revenue(3) of $71M represented 48% of total revenue DAVENPORT, Iowa, May 02, 2024 (GLOBE NEWSWIRE) — Lee Enterprises, Incorporated (NASDAQ: LEE), a digital-first subscription platform providing high quality, trusted, local news, information and a major platform for advertising in 73 markets, today reported preliminary second quarter fiscal 2024 financial results(4) for the period ended March 24, 2024. “Lee delivered strong second quarter operating results as we improved overall revenue trends, managed operating expenses, and grew Adjusted EBITDA,” said Kevin Mowbray, Lee’s President and Chief Executive Officer. “We are pleased with our impressive digital subscription revenue growth and expanding...